a Expression of ETS2 in HCC cancerous and normal tissues from 29 pairs of HCC samples; b Expression of ETS2 in HCC cancerous and normal tissues based on TCGA datasets; c Overall survival of HCC patients grouped by the level of ETS2; d CCK-8 and colony formation assays was applied to determine the viability of ETS2 knockdown cell; e Transwell assays was utilized to evaluate the motility of ETS2 knockdown cells (scale bar, 100 μm). This evidence concerns the gene ETS2 and hepatocellular carcinoma.